CYAD
Celyad Oncology SA American Depositary Shares
CYAD
CYAD
Delisted
CYAD was delisted on the 18th of May, 2023.
8 hedge funds and large institutions have $9.07M invested in Celyad Oncology SA American Depositary Shares in 2022 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
8
Holders Change
–
Holders Change %
0%
% of All Funds
0.14%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
2
Increased
1
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Citadel Advisors
Miami,
Florida
|
+$22K |
2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$16K |
3 |
UBS Group
Zurich,
Switzerland
|
+$6.42K |
Top Sellers
1 |
HF
HRT Financial
New York
|
-$57K |
2 |
Wells Fargo
San Francisco,
California
|
-$1.4K |
3 |
Morgan Stanley
New York
|
-$1.38K |
4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1K |